Effect of homocysteine on nitric oxide production in coronary microvascular endothelial cells

Endothelium: Journal of Endothelial Cell Research

Volumn 14, Issue 3, 2007, Pages 157-161

  Erol, Ayşe ^a   Çnar, Mehtap G ^a   Can, Cenk ^a   Olukman, Murat ^a   Ülker, Sibel ^a   Koşay, Sezen ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Atherosclerosis; Cell culture isolation; Endothelial function; Homocysteine; Nitric oxide

Indexed keywords

CALCIMYCIN; CALCIUM IONOPHORE; CATALASE; HOMOCYSTEINE; INTERLEUKIN 1BETA; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRATE REDUCTASE; NITRIC OXIDE; NITRITE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY BLOOD VESSEL; CULTURE MEDIUM; ENDOTHELIUM CELL; INCUBATION TIME; ISOLATED HEART; MALE; MICROVASCULATURE; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CALCIMYCIN; CELLS, CULTURED; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENZYME INHIBITORS; HOMOCYSTEINE; INTERLEUKIN-1BETA; IONOPHORES; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES;

RATTUS;

EID: 34347245278     PISSN: 10623329     EISSN: 10292373     Source Type: Journal    
DOI: 10.1080/10623320701421487     Document Type: Article

References (33)

1. Bories, P. N. and Bories, C. (1995) Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase. Clinical Chemistry, 41, pp. 904-907.
2. Brattstrom, L. E., Hardebo, J. E. and Hultberg, B. L. (1984) Moderate hyperhomocysteinemia: A possible risk factor for arteriosclerotic cerebrovascular disease. Stroke, 15, pp. 1012-1016.
3. Cai, H. and Harrison, D. G. (2000) Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circulation Research, 87, pp. 840-844.
4. Chow, K., Cheung, F., Lao, T. T. H. and Karmin, O. (1999) Effect of homocysteine on the production of nitric oxide in endothelial cells. Clinical and Experimental Pharmacology and Physiology, 26, pp. 817-818.
5. Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane, S., Fowler, B. and Graham, I. (1991) Hyperhomocysteinemia: An independent risk factor for vascular disease. New England Journal of Medicine, 3324, pp. 1149-1155.
6. De Groote, M. A., Testerman, T., Xu, Y., Stauffer, G. and Fang, F. C. (1996) Homocysteine antagonism of nitric oxide-related cytostasis in. Salmonella typhimurium. Science, 272, pp. 414-417.
7. Dudman, N. P., Hicks, C., Wang, J. and Wilcken, D. E. (1991) Human arterial endothelial cell detachment in vitro: Its promotion by homocysteine and cysteine. Atherosclerosis, 91, pp. 77-83.
8. Giraldez, R. R., Panda, A. and Zweier, J. L. (2000) Endothelial dysfunction does not require loss of endothelial nitric oxide synthase. American Journal of Physiology Heart and Circulatory Physiology, 278, pp. H2020-H2027.
9. Harker, L. A., Ross, R., Slichter, S. J. and Scott, R. (1976) Homocysteine-induced arteriosclerosis: The role of endothelial cell injury and platelet response in its genesis. Journal of Clinical Investigation, 58, pp. 731-741.
10. Ikeda, U., Ikeda, M., Minota, S. and Shimada, K. (1999) Homocysteine increases nitric oxide synthesis in cytokine-stimulated vascular smooth-muscle cells. Circulation, 99, pp. 1230-1235.
11. Kanno, K., Hirata, Y., Imai, T. and Marumo, F. (1993) Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells. Hypertension, 22, pp. 34-39.
12. Kuo, P. C. and Schroeder, R. A. (1995) The emerging multifaceted roles of nitric oxide. Annals of Surgery, 221, pp. 220-235.
13. Lentz, S. R., Sobey, C. G., Piegors, D. J., Bhopatkar, M. Y., Faraci, F. M., Malinow, M. R. and Hesitad, D. D. (1996) Vascular dysfunction in monkeys with diet-induced hyperhomocysteinemia. Journal of Clinical Investigation, 98, pp. 24-29.
14. Lolin, Y. L., Sanderson, J. E., Cheng, S. K., Chan, C. F., Pang, C. P., Woo, K. S. and Masarei, J. R. L. (1996) Hyperhomocysteinemia and premature coronary artery disease in the Chinese. Heart, 76, pp. 117-122.
15. Loscalzo, J. (1996) The oxidant stress of hyperhomocysteinemia. Journal of Clinical Investigation, 98, pp. 5-7.
16. Lowenstein, C. J., Dinerman, J. L. and Snyder, S. H. (1994) Nitric oxide: A physiologic messenger. Annals of Internal Medicine, 120, pp. 227-237.
17. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J. (1951) Protein measurement with the folin phenol reagent. Journal of Biological Chemistry, 193, pp. 265-275.
18. McCully, K. S. (1969) Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. American Journal of Pathology, 56, pp. 111-128.
19. Meleady, R. A., Mulcathy, D. A. and Graham, I. M. (1996) Genes, greens, and homocysteine. Heart, 76, pp. 103-104.
20. Morris Jr., S. M. and Billiar, T. R. (1994) New insights into the regulation of inducible nitric oxide synthesis. American Journal of Physiology, 266, pp. E829-E839.
21. Pethig, K., Hoffman, A., Heublein, B., Timke, A., Gross, G. and Haverich, A. (2000) Cardiac allogarft vascular disease after orthotopic heart transplantation: Methylenetetrahydrofolate reductase gene ploymorphism C677T does not account for rapidly progressive forms. Transplantation, 69, pp. 442-445.
22. Piper, H. M., Spahr, R., Mertens, S., Krytzfeldt, A. and Watanabe, H. (1990) Microvascular endothelial cells from the heart. Cell Culture Techniques in Heart and Vessel Research, pp. 158-177. Springer Verlag, Berlin
23. Russo, G., Leopold, J. A. and Loscalzo, J. (2002) Vasoactive substances: Nitric oxide and endothelial dysfunction in atherosclerosis. Vascular Pharmacology, 38, pp. 259-269.
24. Stamler, J. S., Osborne, J. A., Jaraki, O., Rabbani, L. E., Mullins, M., Singel, D. and Loscalzo, J. (1993) Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. Journal of Clinical Investigation, 91, pp. 308-318.
25. Starkebaum, G. and Harlan, J. M. (1986) Endothelial injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. Journal of Clinical Investigation, 77, pp. 1370-1376.
26. Topal, G., Brunet, A., Millanvoye, E. M., Boucher, J. L., Rendu, F., Devynck, M. A. and David-Dufilho, M. (2004) Homocysteine induces oxidative stress by uncoupling of NO synthase activity through reduction of tetrahydrobiopterin. Free Radical Biology and Medicine, 36, pp. 1532-1541.
27. Tsen, C. M., Hsieh, C. C., Yen, C. H. and Lau, Y. T. (2003) Homocysteine altered ROS generation and NO accumulation in endothelial cells. Chinese Journal of Physiology, 46, pp. 129-136.
28. Tyagi, N., Sedoris, K. C., Steed, M., Ovechkin, A. V., Moshal, K. S. and Tyagi, S. C. (2005) Mechanisms of homocysteine-induced oxidative stress. American Journal of Physiology Heart and Circulatory Physiology, 289, pp. H2649-H2656.
29. Upchurch Jr., G. R., Welch, G., Fabian, A., Freedman, J. E., Johnson, J. L., Keaney Jr., J. F. and Loscalzo, J. (1997) Stimulation of endothelial nitric oxide production by homocysteine. Atherosclerosis, 132, pp. 177-185.
30. Upchurch Jr., G. R., Welch, G. N., Fabian, A. J., Freedman, J. E., Johnson, J. L., Keaney Jr., J. F. and Loscalzo, J. (1997) Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. Journal of Biological Chemistry, 272, pp. 17012-17017.
31. Vallance, P. and Chan, N. (2001) Endothelial function and nitric oxide: Clinical relevance. Heart, 85, pp. 342-350.
32. Ventura, P., Panini, R., Verlata, C., Scarpetta, G. and Salvioli, G. (2000) Peroxidation indices and total antioxidant capacity in plasma during hyperhomocysteinemia induced by methionine loading. Metabolism, 49, pp. 225-228.
33. Wall, R. T., Harlan, J. M., Harker, L. A. and Striker, G. E. (1980) Homocysteine-induced endothelial cell injury in vitro: A model for the study of vascular injury. Thrombosis Research, 18, pp. 113-121.